Stockholders' Equity (Details) - USD ($)			1 Months Ended					9 Months Ended	12 Months Ended
	Dec. 03, 2022	Jun. 14, 2021	Apr. 30, 2022	Mar. 21, 2022	Mar. 18, 2022	Aug. 26, 2021	Jun. 30, 2021	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Aug. 26, 2022
Stockholders' Equity (Details) [Line Items]
Common stock shares authorized									250,000,000	1,000,000,000
Common stock of shares issued				1,063,514	1,063,514				25,319,095	23,294,024
Common stock shares									25,319,095	23,294,024
Preferred stock, authorized									20,000,000
Common stock price per share (in Dollars per share)				$ 3.7	$ 3.03
Gross proceeds (in Dollars)				$ 3,300,000	$ 3,300,000
Credit facility amount (in Dollars)				$ 10,000,000
Amount (in Dollars)									$ 50,000
Accrued interest (in Dollars)									$ 406
Number of shares	479,845								13,514
Interest (in Dollars)	$ 696,000								$ 1,359,954	$ 586,850
Conversion of common shares issued									353,216
Convertible notes totaling (in Dollars)						$ 1,642,856
Converted common stock shares						7				81,000
Exercise shares				28,500		214,285
Gross proceeds (in Dollars)						$ 11,500,000
Convertible Notes Payable, Current (in Dollars)										$ 6.2
Shares of common stock										1,171,000
Common Stock Warrants (in Dollars)				$ 142,690
Exercise price (in Dollars)										$ 3.7
Aggregate common share										64,286
Shares issued (in Dollars)										$ 4.5
Per share price (in Dollars per share)										$ 8.75
Offering price										125.00%
Exercise price per share (in Dollars per share)								$ 3.03
Common stock value (in Dollars)								$ 90,000	$ 3,146,940	$ 10,282,998
Number of shares									93,470
Stock option to board of directors, Description										The Company granted each of the four new Directors appointed June 2021 (“June Directors”) stock options to acquire 62,500 shares of common stock or a total of 250,000 that vest one third a year after each Annual Meeting. Additionally, the Company added another Director in November 2021 and granted stock options to acquire 29,173 shares of common stock that vest one third a year after each Annual Meeting beginning in 2022. One of the June Directors did not stand for reelection to the Board of Directors in December 2021 and forfeited 41,667 stock options. In December 2021, the Company granted additional options to acquire 10,238 shares of common stock to each of the non-employee Directors, by way of annual compensation under the Company’s compensation policy for non-employee directors and which vests monthly over a one-year-period.
Options description									The options for the majority vest annually over a three-year period, 100,000 vest equally over a four-year period, and the balance of 100,000 vest upon the achievement of certain market capitalization thresholds or performance conditions.
Unrecognized compensation costs (in Dollars)									$ 10,000,000
Stock compensation expense (in Dollars)										$ 5,500,000
Restricted stock expense (in Dollars)										$ 1,228,000
Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Number of shares	479,845							34,996	135	756,000,000,000
Converted common stock shares											214,285
Common stock value (in Dollars)									$ 106	$ 164
Exercise feature issued common shares (in Dollars)									$ 31	$ 42
Options [Member]
Stockholders' Equity (Details) [Line Items]
Number of shares									175,000
Performance-based [Member]
Stockholders' Equity (Details) [Line Items]
Number of shares									175,000
Maximum [Member] | Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Number of shares									13,514
Minimum [Member] | Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Number of shares									135
Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Common stock shares authorized									250,000,000
Common stock of shares issued									25,319,095
Common stock shares										23,294,024
Common stock of fair market value (in Dollars per share)				$ 3.03
Employee Stock Option [Member]
Stockholders' Equity (Details) [Line Items]
Stock compensation expense (in Dollars)									$ 8,900,000
Employees [Member]
Stockholders' Equity (Details) [Line Items]
Number of shares									1,674,464
Mr Thimot [Member]
Stockholders' Equity (Details) [Line Items]
Exercise price per share (in Dollars per share)		$ 7.8
Exercise feature issued common shares (in Dollars)									$ 1,200,000
Mr Smith [Member]
Stockholders' Equity (Details) [Line Items]
Exercise price per share (in Dollars per share)		$ 7.8
Warrant term		10 years
Number of shares									600,000
Mr Broenniman [Member]
Stockholders' Equity (Details) [Line Items]
Number of shares									583,333
Stock options to acquire the cancel shares									200,000
Mr Kumnick [Member]
Stockholders' Equity (Details) [Line Items]
Stock options to acquire the cancel shares									300,000
Mr Selzer [Member]
Stockholders' Equity (Details) [Line Items]
Number of shares										22,388
Mr.Stern [Member]
Stockholders' Equity (Details) [Line Items]
Number of shares							6,997
Mr. Trelin [Member]
Stockholders' Equity (Details) [Line Items]
Shares of common stock			100,897
Exercise price (in Dollars)			$ 270,000
Exercise price per share (in Dollars per share)			$ 3.13
Warrant term			10 years
Common stock value (in Dollars)			$ 270,000
Note Investors [Member]
Stockholders' Equity (Details) [Line Items]
Common stock of shares issued									28,496
Credit Facility [Member]
Stockholders' Equity (Details) [Line Items]
Common stock of shares issued				100,000